StairMed Technology, a Shanghai-based startup, has developed a novel brain-machine interface (BCI) implantation method that reduces the procedure time from two hours to approximately ten minutes. Unlike traditional open-brain surgeries, this system utilizes a catheter that enters through the neck vein, reaching the target area in the brain without the need to open the skull.
This innovation is significant as it transforms the BCI implantation process from a complex neurosurgical operation into an outpatient procedure. Dr. Duan Wanru from Xuanwu Hospital noted that a surgeon with 4 to 5 years of experience could complete the procedure in just ten minutes. StairMed's ultra-flexible electrode, measuring only 1 micron in diameter, is designed to penetrate the blood vessel wall and make direct contact with brain tissue, differing from similar technologies that keep electrodes inside the vessel.
StairMed has raised over 1.1 billion RMB (approximately $163 million) in funding over the past year, with major investors including Tencent and Alibaba. While the technology has been tested in sheep, human clinical trials have not yet commenced. If successful, StairMed's ten-minute implantation could revolutionize the pathway for BCIs from laboratory settings to clinical applications.
Editor's Note
The advancements in brain-machine interface technologies, particularly those that reduce surgical complexity and time, are crucial for the future of neurotechnology. As companies like StairMed push the boundaries of BCI development, the competitive landscape will evolve, potentially leading to significant shifts in healthcare delivery and patient outcomes. Stakeholders should monitor regulatory developments and clinical trial outcomes closely.
Leave a comment